MoneyWorks4Me

Dishman Carbogen Amcis gets nod to raise Rs 75 crore via NCDs

12 Aug 2026 Evaluate

Dishman Carbogen Amcis has received approval for the issuance of up to 7,500 Senior, Secured, Rated, Listed, Transferable, Redeemable, Taxable Non-Convertible Debentures (NCDs) of face value of Rs 1,00,000 each, aggregating up to Rs 75 crore on a private placement basis. The said NCDs are proposed to be listed on Wholesale Debt Market Segment of BSE. The Board of Directors of the Company has at its meeting held on August 12, 2026 approved the same. 

Dishman Carbogen Amcis (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators. 


Dishman Carbogen Amc Share Price

189.90 -3.20 (-1.66%)
12-Aug-2026 14:06 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1928.70
Dr. Reddys Labs. 1196.00
Cipla 1461.00
Lupin 2254.50
Zydus Lifesciences 1198.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: